DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Item

http://www.wikidata.org/entity/Q36710620

Q36710620

about

Radiation dose effect in locally advanced non-small cell lung cancer Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.Predictive and prognostic value of tumor volume and its changes during radical radiotherapy of stage III non-small cell lung cancer : A systematic review.DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily: high local control in early stage (I/II) non-small-cell lung cancer.

P2860

Q26823043-C553CA3E-9EC9-4103-8685-7721ED6182B9 Q35669846-D83B5634-7196-486F-95D7-CE398588428F Q37714576-4F26CE91-0D7B-4D57-AE2C-5622B334D95D Q47898194-72D6B035-4345-4574-BCE7-0DE9CE224515 Q53083823-33B9C71B-0C71-47C7-9FC4-2A7256489574

P2860

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Item

http://www.wikidata.org/entity/Q36710620

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@ast

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@en

type

Item

label

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@ast

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@en

prefLabel

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@ast

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@en

P1476

DART-bid (Dose-differentiated ...... adiation dose to tumor volume.

@en

P2093

Bernd Lamprecht

http://www.w3.org/2001/XMLSchema#string

Birgit Wegleitner

http://www.w3.org/2001/XMLSchema#string

Franz Zehentmayr

http://www.w3.org/2001/XMLSchema#string

Heinz Deutschmann

http://www.w3.org/2001/XMLSchema#string

Karin Dagn

http://www.w3.org/2001/XMLSchema#string

Karl Wurstbauer

http://www.w3.org/2001/XMLSchema#string

Michael Studnicka

http://www.w3.org/2001/XMLSchema#string

Peter Kopp

http://www.w3.org/2001/XMLSchema#string

Peter Porsch

http://www.w3.org/2001/XMLSchema#string

P2860

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

Biological factors influencing optimum fractionation in radiation therapy.

Repopulation of tumour cells between cycles of chemotherapy: a neglected factor.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma

Functional dosimetric metrics for predicting radiation-induced lung injury in non-small cell lung cancer patients treated with chemoradiotherapy.

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients.

Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy.

P2888

1748-717x-8-49

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-8-49

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Felix Sedlmayer

P577

2013-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015575068

http://www.w3.org/2001/XMLSchema#string

P698

23497555

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3606417

http://www.w3.org/2001/XMLSchema#string

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

about

P2860

P2860

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932